Jens Ersbøll

1.6k citations
29 papers · 1.1k indexed · h-index 15
Topics
Lymphoma Diagnosis and Treatment (15 papers)Chronic Lymphocytic Leukemia Research (8 papers)Viral-associated cancers and disorders (8 papers)
Partner nations
DenmarkNetherlandsSweden

In The Last Decade

Jens Ersbøll

29 papers receiving 1.1k citations

Peers

Jens Ersbøll
Comparison fields: 5 of 83
  • Pathology and Forensic Medicine 449
  • Oncology 381
  • Hematology 371
  • Genetics 282
  • Molecular Biology 276
Replace R H Herzig with:
R H Herzig United States
Vincenzo Pavone Italy
Ferdinando Frigeri Italy
Paolo Gavarotti Italy
Simone Ferrero Italy
B. Lathan Germany
Burton J. Lee United States
Delvyn C. Case United States
D E Bergsagel Canada
H Kantarjian United States
Jens Ersbøll relative to R H Herzig United States R H Herzig's profile →
Citations per field
00.5×1.5×2.1×
R H Herzig · 1×
Citations per year

Countries citing papers authored by Jens Ersbøll

Since Specialization
Citations

This map shows the geographic impact of Jens Ersbøll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Ersbøll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Ersbøll more than expected).

Fields of papers citing papers by Jens Ersbøll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Ersbøll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Ersbøll. The network helps show where Jens Ersbøll may publish in the future.

Co-authorship network of co-authors of Jens Ersbøll

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Ersbøll. A scholar is included among the top collaborators of Jens Ersbøll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Ersbøll. Jens Ersbøll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 32
2 28
3 27
4 17
5 6
6
Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
9
7
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
152
8 81
9 42
10 75
11 3
12 3
13 136
14 4
15 168
16 7
17
VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
11
18 20
19 5
20
The constipating effect of diphenoxylate (Retardinr) in ulcerative colitis. A double-blind controlled trial.
6

About Jens Ersbøll

Jens Ersbøll is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (8 papers). The work is most often cited by research in Hematology (371 citations), Genetics (282 citations) and Pathology and Forensic Medicine (449 citations). Jens Ersbøll has collaborated with scholars based in Denmark, Netherlands and Sweden. Frequent co-authors include J Pedersen-Bjergaard, Henrik B. Schultz, Nis I. Nissen, K Hou-Jensen, N I Nissen, Mogens Hansen, Lena Specht, J. Struck, Severin Olesen Larsen and N. I. Nissen. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026